Floatz logo

PREDNISONE TABLETS

Steroid-Refractory Pneumonitis

ECOG-ACRIN Cancer Research GroupSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Steroid-Refractory Pneumonitis cohort.

Asset / SponsorPhaseRating
Amifostine
MedImmune LLC
Phase 2B
Tocilizumab
National Cancer Institute (NCI)
Phase 2CCC
HUMAN IMMUNOGLOBULINS
ECOG-ACRIN Cancer Research Group
Phase 2CCC
Infliximab
ECOG-ACRIN Cancer Research Group
Phase 2CCC
POLY(ACETYL, ARGINYL)GLUCOSAMINE (25000-50000 MW)
Synspira, Inc.
Phase 1CC

View all 11 →

Same molecule, other indications

PREDNISONE TABLETS is also rated in:

Recurrent Adult T-cell Leukemia/LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
diffuse large B-cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →